Santosh J. Vetticaden
2012 - Mast Therapeutics
In 2012, Santosh J. Vetticaden earned a total compensation of $631.5K as Chief Medical Officer and Senior Vice President at Mast Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $39,603 |
| Option Awards | $370,860 |
| Salary | $113,750 |
| Other | $7,274 |
| Total | $631,487 |
Vetticaden received $370.9K in option awards, accounting for 59% of the total pay in 2012.
Vetticaden also received $100K in bonus, $39.6K in non-equity incentive plan, $113.8K in salary and $7.3K in other compensation.
Rankings
In 2012, Santosh J. Vetticaden's compensation ranked 7,938th out of 11,487 executives tracked by ExecPay. In other words, Vetticaden earned more than 30.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,938 out of 11,487 | 31st |
Division Manufacturing | 2,866 out of 4,253 | 33rd |
Major group Chemicals And Allied Products | 752 out of 1,203 | 38th |
Industry group Drugs | 535 out of 925 | 42nd |
Industry Pharmaceutical Preparations | 420 out of 700 | 40th |
Source: SEC filing on April 29, 2014.
Vetticaden's colleagues
We found two more compensation records of executives who worked with Santosh J. Vetticaden at Mast Therapeutics in 2012.